Berberine Prevent Contrast-induced Nephropathy in Patients With Diabetes
Multicenter Randomized Controlled Study of Berberine for Prevention of Contrast-Induced Acute Kidney Injury in Patients With Diabetes and Renal Insufficient
Sponsor: Nanjing First Hospital, Nanjing Medical University
This PHASE4 trial investigates Chronic Kidney Disease and Diabetes Mellitus and is currently completed. Nanjing First Hospital, Nanjing Medical University leads this study, which shows 10 recorded versions since 2016 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Apr 2022 — Jul 2024 [monthly]
Completed PHASE4
Status: Recruiting → Completed
-
Apr 2021 — Apr 2022 [monthly]
Recruiting PHASE4
-
Jan 2021 — Apr 2021 [monthly]
Recruiting PHASE4
▶ Show 5 earlier versions
-
Aug 2020 — Jan 2021 [monthly]
Recruiting PHASE4
-
Jan 2020 — Aug 2020 [monthly]
Recruiting PHASE4
-
Jun 2018 — Jan 2020 [monthly]
Recruiting PHASE4
-
Feb 2017 — Jun 2018 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Jan 2017 — Feb 2017 [monthly]
Not Yet Recruiting PHASE4
First recorded
Jul 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Nanjing First Hospital, Nanjing Medical University
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Nanjing, China